Literature DB >> 6530610

Motor neuron disease in the province of Turin, Italy, 1966-1980. Survival analysis in an unselected population.

P Mortara, A Chiò, M G Rosso, M Leone, D Schiffer.   

Abstract

We performed a population based survival analysis of all incident cases (220) of motor neuron disease (MND) in the province of Turin, Italy, during the period 1966-1980. 175 cases were diagnosed as amyotrophic lateral sclerosis (ALS), 43 as progressive muscular atrophy (PMA) and 2 as progressive bulbar palsy (PBP). The life-tables of MND, adjusted as to the "expected" mortality, showed a survival rate of 27.8% and 22.0% at 5 and 10 years, respectively. The course of PMA and ALS cases was different, with a 5-year survival rate of 66.8% and 17.7%, respectively. Nevertheless both life-tables showed a similar pattern with a rapidly fatal outcome in the first 3 years after diagnosis and a slower death rate in the following years. In each curve, the slopes suggested the presence of 2 subgroups with different prognosis. It is to be stressed that a percentage of PMA patients (25.7%) showed a rapidly fatal outcome and that a subgroup of ALS patients (26.6%) showed a relatively benign course. This might suggest a different individual susceptibility to the disease.

Entities:  

Mesh:

Year:  1984        PMID: 6530610     DOI: 10.1016/0022-510x(84)90004-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

1.  Patients who survive 5 years or more with ALS in Olmsted County, 1925-2004.

Authors:  Farrah J Mateen; Marco Carone; Eric J Sorenson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-07-13       Impact factor: 10.154

Review 2.  The epidemiology of ALS: a conspiracy of genes, environment and time.

Authors:  Ammar Al-Chalabi; Orla Hardiman
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

3.  Amyotrophic lateral sclerosis in Palermo, Italy: an epidemiological study.

Authors:  G Salemi; B Fierro; A Arcara; M Cassata; M G Castiglione; G Savettieri
Journal:  Ital J Neurol Sci       Date:  1989-10

4.  Preclinical and subclinical events in motor neuron disease.

Authors:  M Swash; D Ingram
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

Review 5.  Prognostic factors in ALS: A critical review.

Authors:  Adriano Chiò; Giancarlo Logroscino; Orla Hardiman; Robert Swingler; Douglas Mitchell; Ettore Beghi; Bryan G Traynor
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

6.  Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis.

Authors:  A Chiò; C Magnani; E Oddenino; G Tolardo; D Schiffer
Journal:  J Epidemiol Community Health       Date:  1992-10       Impact factor: 3.710

7.  Multiple sclerosis and motor neurone disease: survival and how certified after death.

Authors:  F O'Malley; G Dean; M Elian
Journal:  J Epidemiol Community Health       Date:  1987-03       Impact factor: 3.710

Review 8.  A fruitful endeavor: modeling ALS in the fruit fly.

Authors:  Ian Casci; Udai Bhan Pandey
Journal:  Brain Res       Date:  2014-10-05       Impact factor: 3.252

9.  Natural history and clinical features of the flail arm and flail leg ALS variants.

Authors:  L C Wijesekera; S Mathers; P Talman; C Galtrey; M H Parkinson; J Ganesalingam; E Willey; M A Ampong; C M Ellis; C E Shaw; A Al-Chalabi; P N Leigh
Journal:  Neurology       Date:  2009-03-24       Impact factor: 9.910

10.  A proposed staging system for amyotrophic lateral sclerosis.

Authors:  Jose C Roche; Ricardo Rojas-Garcia; Kirsten M Scott; William Scotton; Catherine E Ellis; Rachel Burman; Lokesh Wijesekera; Martin R Turner; P Nigel Leigh; Christopher E Shaw; Ammar Al-Chalabi
Journal:  Brain       Date:  2012-01-23       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.